Ownership and insider activity for NRC Health (NRC): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences.
Price
| Price | $22.05 |
| Market Cap | $497M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-06-23 | Berwick Donald M | A-Award | 7,697 | |
| 2026-06-23 | Bhandari Parul | A-Award | 7,697 | |
| 2026-06-23 | Lockhart Stephen H | A-Award | 7,697 | |
| 2026-06-23 | NUNNELLY JOHN N | A-Award | 7,697 | |
| 2026-06-23 | Wheeler Penny Ann | A-Award | 7,697 | |
| 2026-03-12 | Rau Jason Russell | A-Award | 60,000 | |
| 2026-02-17 | HARRISON SHANE R | P-Purchase | 8,000 | $98K |
| 2026-01-22 | Lockhart Stephen H | A-Award | 8,819 | $194K |
| 2026-01-22 | Bhandari Parul | A-Award | 8,819 | $194K |
| 2025-12-29 | HARRISON SHANE R | F-InKind | 21,271 | $397K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $33.0M | $34.7M | $13.0M | $13.5M | $34.7M | $54.4M | $25.0M | $6.7M | $4.2M | $4.1M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $12.4M | $15.2M | $12.0M | $11.8M | $15.5M | $14.6M | $15.3M | $12.6M | $11.2M | $11.6M |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $47.1M | $52.3M | $28.1M | $29.2M | $54.1M | $73.7M | $43.7M | $24.4M | $19.6M | $20.2M |
| Property, Plant & Equipment | $11.8M | $12.4M | $14.2M | $15.2M | $13.0M | $13.4M | $17.8M | $30.3M | $39.9M | $40.5M |
| Goodwill | $57.9M | $58.0M | $57.8M | $57.9M | $57.3M | $61.6M | $61.6M | $61.6M | $66.2M | $66.2M |
| Intangible Assets | $3.1M | $2.8M | $2.1M | $1.7M | $1.4M | $1.8M | $1.6M | $1.5M | $2.6M | $2.2M |
| Total Assets | $120.6M | $127.3M | $107.7M | $110.7M | $133.4M | $157.5M | $130.5M | $122.4M | $132.5M | $134.9M |
| Accounts Payable | $765000 | $593000 | $613000 | $1.3M | $1.1M | $1.9M | $1.2M | $1.3M | $1.2M | $4.1M |
| Short-term Debt | $2.7M | $1.1M | $3.7M | $5.1M | $5.0M | $5.2M | $5.3M | $7.8M | $4.8M | $4.0M |
| Total Current Liabilities | $31.5M | $32.3M | $46.8M | $38.2M | $31.7M | $40.4M | $33.4M | $36.2M | $35.9M | $36.6M |
| Long-term Debt | $857000 | 0 | $34.2M | $29.8M | $26.5M | $22.3M | $17.7M | $29.5M | $57.9M | $75.0M |
| Total Liabilities | $37.8M | $37.3M | $88.6M | $77.8M | $69.1M | $72.2M | $58.4M | $73.5M | $101.3M | $120.9M |
| Retained Earnings | $71.5M | $77.6M | -$106.3M | -$93.4M | -$61.4M | -$36.1M | -$25.2M | -$30.5M | -$17.1M | -$17.3M |
| Total Equity | $82.8M | $90.0M | $19.1M | $32.9M | $64.3M | $85.3M | $72.0M | $49.0M | $31.3M | $14.0M |
| Total Debt | $2.7M | $1.1M | $3.7M | $36.6M | $33.2M | $28.7M | $23.4M | $39.0M | $64.4M | $79.0M |
| Net Debt | -$30.3M | -$33.7M | -$9.3M | $23.1M | -$1.5M | -$25.7M | -$1.6M | $32.3M | $60.2M | $74.9M |
| Working Capital | $15.6M | $19.9M | -$18.7M | -$9.0M | $22.4M | $33.3M | $10.3M | -$11.8M | -$16.3M | -$16.4M |
Financial Health
| Debt / Equity | 13.75 |
| Current Ratio | 0.65 |
Profitability
| Return on Equity | 48.46% |
| Return on Invested Capital | 8.75% |
| Return on Assets | 4.30% |
| Gross Margin | 66.79% |
| Operating Margin | 10.53% |
| Net Margin | 4.18% |
Related companies: DH · HCAT · NNOX · PBYI · QTRX · SNWV · SOPH
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of NRC: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks